EHRA Premium Access

Acute procedural characteristics, efficacy, and safety of a novel cryoballoon for the treatment of paroxysmal atrial fibrillation: Results from the POLAR-ICE study

Congress Session

About the speaker

Doctor Sing-Chien Yap

Erasmus University Medical Center, Rotterdam (Netherlands (The))
7 presentations
0 follower

7 more presentations in this session

Comparison between oral procainamide and mexiletine for the treatment of recurrent and refractory ventricular tachyarrhythmias.

Speaker: Doctor M. Toniolo (Udine, IT)

Thumbnail

Is it possible to predict mortality and recurrence of VT afterablation? PAINESD risk score applicability vs new predictors

Speaker: Doctor J. Brito (Lisbon, PT)

Thumbnail

Effectiveness and safety of bipolar ablation of heart arrhythmia. A systematic review with meta-analysis.

Speaker: Doctor M. Farkowski (Warsaw, PL)

Thumbnail

Quantifying the variability of bipolar voltage amplitude with sensing angle in residual conduction isthmuses in atrial scar

Speaker: Doctor M. Martinez Cossiani (Madrid, ES)

Thumbnail

Validation of the peak frequency of bipolar electrograms for detection of residual conduction in atrial scar tissue

Speaker: Doctor M. Martinez Cossiani (Madrid, ES)

Thumbnail

Access the full session

Moderated ePosters - Variety on how to improve treatment of arrhythmias

Speakers: Doctor S. Yap, Doctor M. Toniolo, Doctor J. Brito, Doctor M. Farkowski, Doctor M. Martinez Cossiani...
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Related content

EHRA Premium Access

Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures

3 April 2022

EHRA Premium Access

Biventricular versus conduction system pacing after atrioventricular node ablation in heart failure patients with atrial fibrillation

3 April 2022

EHRA Premium Access

Selective epicardial pulsed field ablation of atrial ganglionated plexi causes anti-arrhythmic prolongation of refractoriness: demonstration of feasibility in cardiac surgery patients

3 April 2022

This platform is supported by

logo Novo Nordisk